DARUMA CAPITAL MANAGEMENT LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
DARUMA CAPITAL MANAGEMENT LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$6,746,000
-65.9%
177,242
-61.4%
0.77%
-70.9%
Q4 2018$19,770,000
-20.8%
459,561
-9.5%
2.63%
+12.0%
Q3 2018$24,951,000
-34.1%
507,640
-57.0%
2.35%
-4.3%
Q2 2018$37,859,000
+6.9%
1,181,250
+3.9%
2.46%
+11.3%
Q1 2018$35,424,000
-37.0%
1,137,220
-7.6%
2.21%
-37.0%
Q4 2017$56,188,000
+22.4%
1,230,854
+0.7%
3.50%
+22.5%
Q3 2017$45,911,000
-14.2%
1,222,655
+9.0%
2.86%
-10.4%
Q2 2017$53,516,000
+1.3%
1,121,925
-3.2%
3.19%
+3.6%
Q1 2017$52,837,000
+34.1%
1,158,699
-5.0%
3.08%
+37.3%
Q4 2016$39,394,000
-5.6%
1,219,642
-0.0%
2.24%
-12.0%
Q3 2016$41,750,000
+15.0%
1,220,044
+13.3%
2.55%
+7.5%
Q2 2016$36,318,000
-28.8%
1,076,724
+11.8%
2.37%
-25.7%
Q1 2016$51,029,000
-29.9%
963,184
+1.6%
3.19%
-26.8%
Q4 2015$72,819,000
+70.0%
948,283
-9.0%
4.36%
+65.7%
Q3 2015$42,827,000
-9.3%
1,042,012
+56.0%
2.63%
+26.9%
Q2 2015$47,232,000
-19.5%
667,877
+1.2%
2.07%
-20.9%
Q1 2015$58,641,000
-4.1%
659,998
-4.3%
2.62%
-1.4%
Q4 2014$61,142,000
-22.5%
689,628
-15.3%
2.66%
-23.3%
Q3 2014$78,938,000
-24.1%
814,470
-28.1%
3.47%
-18.5%
Q2 2014$104,036,000
+8.4%
1,132,552
-17.4%
4.26%
+11.8%
Q1 2014$95,959,000
+28.0%
1,371,042
+5.1%
3.81%
+22.4%
Q4 2013$74,978,000
+263.0%
1,304,190
+203.5%
3.11%
+228.2%
Q3 2013$20,657,000
+6395.9%
429,688
+3812.7%
0.95%
+6220.0%
Q2 2013$318,00010,9820.02%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders